Literature DB >> 24700283

CTNNB1 mutational analysis of solid-pseudopapillary neoplasms of the pancreas using endoscopic ultrasound-guided fine-needle aspiration and next-generation deep sequencing.

Yoshimasa Kubota1, Hiroshi Kawakami, Mitsuteru Natsuizaka, Kazumichi Kawakubo, Katsuji Marukawa, Taiki Kudo, Yoko Abe, Kimitoshi Kubo, Masaki Kuwatani, Yutaka Hatanaka, Tomoko Mitsuhashi, Yoshihiro Matsuno, Naoya Sakamoto.   

Abstract

BACKGROUND: Solid-pseudopapillary neoplasm (SPN), a rare neoplasm of the pancreas, frequently harbors mutations in exon 3 of the cadherin-associated protein beta 1 (CTNNB1) gene. Here, we analyzed SPN tissue for CTNNB1 mutations by deep sequencing using next-generation sequencing (NGS).
METHODS: Tissue samples from 7 SPNs and 31 other pancreatic lesions (16 pancreatic ductal adenocarcinomas (PDAC), 11 pancreatic neuroendocrine tumors (PNET), 1 acinar cell carcinoma, 1 autoimmune pancreatitis lesion, and 2 focal pancreatitis lesions) were analyzed by NGS for mutations in exon 3 of CTNNB1.
RESULTS: A single-base-pair missense mutations in exon 3 of CTNNB1 was observed in all 7 SPNs and in 1 of 11 PNET samples. However, mutations were not observed in the tissue samples of any of the 16 PDAC or other four pancreatic disease cases. The variant frequency of CTNNB1 ranged from 5.4 to 48.8 %.
CONCLUSIONS: Mutational analysis of CTNNB1 by NGS is feasible and was achieved using SPN samples obtained by endoscopic ultrasound-guided fine needle aspiration.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24700283     DOI: 10.1007/s00535-014-0954-y

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  37 in total

1.  Solid-pseudopapillary tumor of the pancreas: immunohistochemical localization of neuroendocrine markers and CD10.

Authors:  K Notohara; S Hamazaki; C Tsukayama; S Nakamoto; K Kawabata; K Mizobuchi; K Sakamoto; S Okada
Journal:  Am J Surg Pathol       Date:  2000-10       Impact factor: 6.394

2.  Analysis of beta-catenin gene mutations in pancreatic tumors.

Authors:  B Gerdes; A Ramaswamy; B Simon; T Pietsch; D Bastian; M Kersting; R Moll; D Bartsch
Journal:  Digestion       Date:  1999 Nov-Dec       Impact factor: 3.216

3.  Clinicopathological analysis of β-catenin and Axin-1 in solid pseudopapillary neoplasms of the pancreas.

Authors:  Shih-Chiang Huang; Kwai-Fong Ng; Ta-Sen Yeh; Hao-Cheng Chang; Chia-Yi Su; Tse-Ching Chen
Journal:  Ann Surg Oncol       Date:  2011-07-19       Impact factor: 5.344

4.  Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations.

Authors:  Susan C Abraham; David S Klimstra; Robb E Wilentz; Charles J Yeo; Kevin Conlon; Murray Brennan; John L Cameron; Tsung-Teh Wu; Ralph H Hruban
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

5.  Endoscopic ultrasound-guided fine-needle aspiration for diagnosis of solid pseudopapillary tumors of the pancreas: a multicenter experience.

Authors:  N Jani; J Dewitt; M Eloubeidi; S Varadarajulu; V Appalaneni; B Hoffman; W Brugge; K Lee; A Khalid; K McGrath
Journal:  Endoscopy       Date:  2007-12-07       Impact factor: 10.093

6.  Structure of a beta-TrCP1-Skp1-beta-catenin complex: destruction motif binding and lysine specificity of the SCF(beta-TrCP1) ubiquitin ligase.

Authors:  Geng Wu; Guozhou Xu; Brenda A Schulman; Philip D Jeffrey; J Wade Harper; Nikola P Pavletich
Journal:  Mol Cell       Date:  2003-06       Impact factor: 17.970

Review 7.  Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors.

Authors:  Günter Klöppel; Guido Rindi; Martin Anlauf; Aurel Perren; Paul Komminoth
Journal:  Virchows Arch       Date:  2007-08-08       Impact factor: 4.064

8.  The use of endoscopic ultrasound in the diagnosis of solid pseudopapillary tumors of the pancreas in children.

Authors:  Evan P Nadler; Anna Novikov; Brian R Landzberg; Mark B Pochapin; Barbara Centeno; Thomas J Fahey; Nitsana Spigland
Journal:  J Pediatr Surg       Date:  2002-09       Impact factor: 2.545

9.  Human equilibrative nucleoside transporter 1 and Notch3 can predict gemcitabine effects in patients with unresectable pancreatic cancer.

Authors:  K Eto; H Kawakami; M Kuwatani; T Kudo; Y Abe; S Kawahata; A Takasawa; M Fukuoka; Y Matsuno; M Asaka; N Sakamoto
Journal:  Br J Cancer       Date:  2013-03-14       Impact factor: 7.640

10.  Molecular evidence for the bi-clonal origin of neuroendocrine tumor derived metastases.

Authors:  Beate Rinner; Birgit Gallè; Slave Trajanoski; Carina Fischer; Martina Hatz; Theresa Maierhofer; Gabriele Michelitsch; Farid Moinfar; Ingeborg Stelzer; Roswitha Pfragner; Christian Guelly
Journal:  BMC Genomics       Date:  2012-11-05       Impact factor: 3.969

View more
  4 in total

1.  Molecular genetic changes in solid pseudopapillary neoplasms (SPN) of the pancreas.

Authors:  Elisa Rodriguez-Matta; Amanda Hemmerich; Jason Starr; Kabir Mody; Eric A Severson; Gerardo Colon-Otero
Journal:  Acta Oncol       Date:  2020-07-16       Impact factor: 4.089

2.  Diagnosis of pancreatic lesions collected by endoscopic ultrasound-guided fine-needle aspiration using next-generation sequencing.

Authors:  Eri Kameta; Kazuya Sugimori; Takashi Kaneko; Tomohiro Ishii; Haruo Miwa; Takeshi Sato; Yasuaki Ishii; Soichiro Sue; Tomohiko Sasaki; Yuki Yamashita; Wataru Shibata; Naomichi Matsumoto; Shin Maeda
Journal:  Oncol Lett       Date:  2016-09-21       Impact factor: 2.967

3.  Factors of Endoscopic Ultrasound-Guided Tissue Acquisition for Successful Next-Generation Sequencing in Pancreatic Ductal Adenocarcinoma.

Authors:  Jae Keun Park; Ji Hyeon Lee; Dong Hyo Noh; Joo Kyung Park; Kyu Taek Lee; Jong Kyun Lee; Kwang Hyuck Lee; Kee-Taek Jang; Juhee Cho
Journal:  Gut Liver       Date:  2020-05-15       Impact factor: 4.519

Review 4.  Evaluating Pancreatic and Biliary Neoplasms with Small Biopsy-Based Next Generation Sequencing (NGS): Doing More with Less.

Authors:  Ilias P Nikas; Giannis Mountzios; Guy I Sydney; Kalliopi J Ioakim; Jae-Kyung Won; Panagiotis Papageorgis
Journal:  Cancers (Basel)       Date:  2022-01-13       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.